Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

5.5%

3 terminated out of 55 trials

Success Rate

88.9%

+2.3% vs benchmark

Late-Stage Pipeline

15%

8 trials in Phase 3/4

Results Transparency

21%

5 of 24 completed with results

Key Signals

5 with results89% success

Data Visualizations

Phase Distribution

54Total
Not Applicable (28)
Early P 1 (2)
P 1 (5)
P 2 (11)
P 3 (3)
P 4 (5)

Trial Status

Completed24
Unknown16
Recruiting5
Withdrawn4
Terminated3
Active Not Recruiting2

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (55)

Showing 20 of 20 trials
NCT05196373Phase 1WithdrawnPrimary

Safety, Tolerability, Pharmacokinetics, Immunogenicity and Efficacy of STP705 in Adult Patients With Hypertrophic Scars

NCT07718269Phase 4Completed

Microneedling vs. 5-Fluorouracil or Steroid Injections for Hypertrophic Scars and Keloids

NCT06487910Not ApplicableRecruiting

Differential Pressure Distribution Orthosis by 3D Printing Process in the Treatment of Post-burn Hypertrophic Scarring

NCT05434897Phase 1CompletedPrimary

A Study to Evaluate the Safety, Tolerability and Efficacy of AK3280 Cream on Hypertrophic Scar

NCT07147166Not ApplicableRecruiting

Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy

NCT03692273Not ApplicableCompleted

Randomized Control Trial of CO2 Laser to Treat Hypertrophic Burn Scar

NCT05478551Phase 2Active Not Recruiting

Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization

NCT04364217Not ApplicableWithdrawnPrimary

Pain and Itch Reduction in Burn Scars Treated With Fractional CO2 Laser

NCT07263100Not ApplicableCompletedPrimary

Comparative Study Between Intralesional Corticosteroid Injection Alone and Combined Intralesional Corticosteroid Injection With Either Long-pluse Nd YAG or Erbium Yag for Treating Hypertrophic or Keloid Scars

NCT07209891Not ApplicableCompletedPrimary

COMPARISON STUY OF KINESIOTAPE AND LOW-LEVEL LASER THERAPY ON HYPERTROPHIC SCAR

NCT03561376Early Phase 1Recruiting

Zinc Oxide Versus Petrolatum Following Skin Surgery

NCT03887377Phase 2Completed

The Efficacy and Molecular Mechanism of Botulinum Toxin in the Reduction of Breast Reduction Mammoplasty Scar Formation

NCT06940999Not ApplicableActive Not RecruitingPrimary

An Innovative Image-Based Method for Extensibility Assessment

NCT06913257Not ApplicableRecruitingPrimary

Cost-Effectiveness of ESWT Plus Rehabilitation vs Rehabilitation Alone in Post-Burn Scars

NCT06909812Phase 3Completed

Silicone vs Pirfenidone in the Treatment of Hypertrophic Scars and Keloids

NCT04506255Not ApplicableRecruitingPrimary

Silicone Taping for the Improvement of Abdominal Donor Site Scars

NCT05259137Phase 2WithdrawnPrimary

Intra-lesional ACE Inhibitor for Treatment of Hypertrophic Scars

NCT06803472Not ApplicableNot Yet RecruitingPrimary

Pulsed High Intensity Laser Versus Extracorporeal Shockwave Therapy on Hypertrophic Scar Post Burn

NCT06033430Not ApplicableUnknown

Effectiveness of Dry Needling in Linear Scar Tissue

NCT06347081Not ApplicableCompletedPrimary

Effect of Nd-YAG Laser on Hypertrophic Scar

Scroll to load more

Research Network

Activity Timeline